PROCEPT BioRobotics Corporation (NASDAQ: PRCT)

This investigation is for anyone who acquired securities in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) prior to February 25, 2026.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by stuffing the Company’s channels of distribution to overstate revenue.

On February 25, 2026, Procept reported fourth quarter and full year 2025 results, disclosing a larger-than-expected adjusted EBITDA loss and cutting its full-year 2026 revenue guidance to a range of $390 million to $410 million (down from its prior range of $410 million to $430 million). The Company attributed lower U.S. consumable revenue in part to eliminating its historical practice of providing discounts on bulk purchases in order to better align handpiece sales with procedure volumes. On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) prior to February 25, 2026 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.